相关实验视频

Updated: Jul 18, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

分子印制聚合物针对4-博-L-烯氨酸-合成优化,理论分析,形态学研究,细胞毒性和释放研究

Emilia Balcer^1,2, Monika Sobiech³, Joanna Giebułtowicz¹

¹Department of Drug Chemistry, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.

|July 29, 2023

概括

这项研究开发了特定的分子印记聚合物 (MIP) 用于4-罗-L-氨 (BPA) 输送. 这些非细胞毒性MIP显示出在生物医学应用中作为有效的化合物载体的潜力.

科学领域:

材料科学材料科学材料科学
生物医学工程生物医学工程
聚合物化学聚合物化学

背景情况:

开发有针对性的药物输送系统对于生物医学应用至关重要.
对于特定的治疗策略,需要化合物载体.
分子印记聚合物 (MIP) 提供量身定制的分子识别能力.

研究的目的:

合成和表征具有高特异性的分子印记聚合物 (MIP) 对4-罗-L-氨 (BPA).
评估这些MIP作为生物医学应用中化合物的有效载体的潜力.

主要方法:

使用甲基烯酸和乙烯基甘醇二甲基烯酸盐合成蜂状MIP.
描述MIP的吸附特性,形态 (SEM) 和结构.
在A549和V79-4细胞系上评估BPA释放概况和细胞毒性测定.

主要成果:

MIP 的结合能力为 330.4 ± 4.6 ng g-1 ,印记因子为 2.04.
扫描电子显微镜证实了一个有序的,多孔形态.
在两个小时内观察到最小的BPA释放 (0-4.81%),没有显著的细胞毒性.

结论:

合成的MIP表明有效的BPA结合和低释放,表明其适合作为化合物载体.
MIPs的非细胞毒性支持其生物医学应用的潜力.
进一步的研究是有必要的,以探索这些MIP在先进的治疗交付系统.

关键词:

4 - 罗-L-氨氨酸是什么?子载体子载体细胞毒性细胞毒性有分子印记的聚合物.形态学形态学形态学

更多相关视频

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

Facile Protocol for the Synthesis of Self-assembling Polyamine-based Peptide Amphiphiles PPAs and Related Biomaterials

Published on: June 25, 2018

相关概念视频

Production of Pharmaceuticals

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...